No Investment advice!
Only for practicing.
Interessting volume spikes in the past.
Upcoming Catalsyst:
DARE-BV1
Bacterial Vaginosis
1H 2021 Phase 3 trial met primary endpoint - December 7, 2020. NDA planned for 1H 2021.
*Phase 1
DARE-HRT1
Hormone replacement therapy
2021 Phase 1 initiation announced July 27, 2020. Data due 2021.
*Phase 2b
Sildenafil Cream, 3.6%
Female Sexual Arousal Disorder (FSAD)
2021 Phase 1 initiation announced July 27, 2020. Data due 2021.
*
Phase 3
Ovaprene
Contraception
2022 Pivotal trial data due in 2022.
Only for practicing.
Interessting volume spikes in the past.
Upcoming Catalsyst:
DARE-BV1
Bacterial Vaginosis
1H 2021 Phase 3 trial met primary endpoint - December 7, 2020. NDA planned for 1H 2021.
*Phase 1
DARE-HRT1
Hormone replacement therapy
2021 Phase 1 initiation announced July 27, 2020. Data due 2021.
*Phase 2b
Sildenafil Cream, 3.6%
Female Sexual Arousal Disorder (FSAD)
2021 Phase 1 initiation announced July 27, 2020. Data due 2021.
*
Phase 3
Ovaprene
Contraception
2022 Pivotal trial data due in 2022.
註釋
交易結束：目標達成
nice spike! Hit my Target
Join Discord channel:
whop.com/marketplace/contingent-traders/
contingenttrader.com/
whop.com/marketplace/contingent-traders/
contingenttrader.com/
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
Join Discord channel:
whop.com/marketplace/contingent-traders/
contingenttrader.com/
whop.com/marketplace/contingent-traders/
contingenttrader.com/
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。